Location History:
- Kanagawa, JP (2009)
- Tokyo, JP (2007 - 2010)
- Osaka, JP (2010 - 2020)
Company Filing History:
6 out of 257 
4 out of 389 
2 out of 73 
Years Active: 2007-2020
Title: Innovator Masahiro Okuyama: Pioneering Heterocyclic Compounds in Osaka
Introduction
Masahiro Okuyama, a renowned inventor based in Osaka, Japan, has made significant contributions to the field of pharmaceutical chemistry with a focus on heterocyclic compounds. With an impressive portfolio that includes 11 patents, Okuyama’s work continually pushes the boundaries of innovation in drug development.
Latest Patents
Among his most recent patents is a groundbreaking discovery related to bicyclic heterocyclic compounds. This novel compound demonstrates a superior inhibitory action on KAT-II, offering promising potential for pharmaceutical applications. The patent includes a detailed production method and describes the compound’s use in a pharmaceutical composition that enhances its therapeutic efficacy. Furthermore, he has developed a bicyclic or tricyclic heterocyclic compound, represented by a specific formula, in which ring A can be an optionally substituted aromatic group, showcasing his inventive capabilities.
Career Highlights
Masahiro Okuyama has had a notable career, with impactful roles at leading pharmaceutical companies. He worked at Mitsubishi Tanabe Pharma Corporation, where he significantly contributed to advancing drug formulations. His collaboration with Sanofi-Aventis further underscores his expertise in the pharmaceutical sector, bringing innovative treatments to the market.
Collaborations
Throughout his career, Okuyama has collaborated with esteemed professionals in his field. Notable coworkers include Fumiaki Uehara and Yoshihiro Usui, with whom he has worked on various innovative projects. Such collaborations have enriched his research and culminated in several successful patent applications.
Conclusion
Masahiro Okuyama stands as a pivotal figure in the realm of pharmaceutical innovation, with a focused specialization in heterocyclic compounds. His contributions through well-defined patents and collaborations with key industry players underscore the importance of innovation in advancing healthcare solutions. As he continues his work from Osaka, the impact of his inventions is poised to further benefit the pharmaceutical industry and the patients who rely on these advancements.